ExAdEx-Innov has been selected as one of only five startups worldwide to participate in the prestigious L’Oréal Innovation Village during the 13th World Congress on Alternatives and Animal Use in the Life Sciences (WC13), taking place from August 31 to September 4, 2025, in Rio de Janeiro, Brazil.
This international recognition highlights the impact and relevance of our technologies designed to reduce—and ultimately go beyond—animal experimentation in research.
The 13th World Congress on Alternatives and Animal Use in the Life Sciences (WC13) is the leading international event dedicated to advancing the 3R principles—Replacement, Reduction, and Refinement—in scientific research and regulatory testing. WC13 brings together scientists, policymakers, industry leaders, and regulatory authorities from around the world to discuss and promote innovative methods that reduce reliance on animal models while improving research quality and relevance. As the premier platform shaping the future of humane and scientifically sound life sciences, WC13 plays a crucial role in driving global progress toward more ethical and sustainable research practices.
At this major global event, we will present our human-relevant New Approach Methodologies (NAMs) to leading experts in the field, within L’Oréal’s dedicated innovation space—an initiative showcasing cutting-edge solutions aligned with the 3Rs principles (Replacement, Reduction, Refinement).
Being chosen in such a context is a significant milestone in our journey to help reshape current scientific standards by offering innovative, responsible research solutions without compromising on scientific excellence.
We’re honored to join the L’Oréal teams and fellow innovators to collectively advance a new era of scientific research—both visionary and compassionate.
📌 More about WC13: Official congress website
📌 Follow us on LinkedIn for updates and behind-the-scenes insights from the event.
EXADEX-INNOV will be participating in the 35th IFSCC Congress, the world’s premier cosmetic science congress, taking place in Cannes from September 15–18, 2025 VISIT
ExAdEx-Innov has presented case study applications of its proprietary tissue models for cosmetic research at COSM’ING 2025 ExAdEx-Innov was delighted to participate in COSM’ING 2025,
ExAdEx-Innov contributes to Landmark Review on Nanofat in Regenerative Medicine We are delighted to announce the publication of our latest collaborative research with our partners
Copyright © 2022 ExAdEx-Innov All rights reserved
KOL on adipose tissue biology.
Research Director (DR1 INSERM).
Team Leader of « Stem Cells and Differentiation » Lab at Institut de Biologie Valrose (Nice).
Label of Laboratoire d’Excellence by the French National Research Agency (Investissements pour le Futur, Labex Signalife program).
Co-inventor of 5 patents
Expert in clinical applications of adipose tissue.
Plastic Reconstructive and Aesthetic Surgeon in Nice.
Member of the Medical Council of Alpes Maritimes region.
Expert for the French National Regulatory Agency ANSM for medical devices.
Certified by French Health Autority HAS (2020-2024).
PhD thesis (2018) on fat tissue and adipose tissue stem cells grafting.
Expert in cell therapy and immunology.
Senior Lecturer (Maitre de conférences).
Responsible of the Cell and Gene Therapy Unity of Nice University Hospital (CHU de Nice).
Director of « Micoralis » research team at Université Côte d’Azur (Nice).
Founder and CEO of the biotech company Biointerférence (2003-2006).
Co-inventor of 5 patents.
Vincent is responsible of company strategy and technological innovation, thanks to his double skill set in science and deeptech startup development.
With a deep knowledge and vision about ExAdEx technology, Vincent has actively worked as a deeptech entrepreneur to push further the development of breakthrough innovative products around human adipose tissue, which lead him to create ExAdEx-Inov.
In addition to his entrepreneurial skills, Vincent has a strong background in biology (PhD in Cellular and Molecular Biology from Université Côte d’Azur) and training in clinical research management (CRA training at the Faculty of Medicine of La Timone, Marseille).
He is co-inventor of the 2 company’s patent families.
Main areas of expertise: DeepTech entrepreneur; Bioengineering of human adipose tissue.
Luigi is responsible of the management of company operations and business development strategy, thanks to his expertise in biotech startup development.
With a double competence and training in business and science (including an MBA from IAE Paris Sorbonne Business School and a PhD in Cytological Sciences from Rome University La Sapienza), Luigi has been managing business development and R&D projects in a preclinical CRO and a biotech startup company in previous years.
He has been supporting ExAdEx-Innov project and business development since his position as an Entrepreneur in Residence for CNRS Innovation Tech Transfer Office in 2021.
Main areas of expertise: Biotech Startup Business Development; Project management
